Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
5,169,697
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
15,151,664
-
Shares change
-
+565,101
-
Total reported value, excl. options
-
$152,959,000
-
Value change
-
+$5,823,455
-
Number of buys
-
34
-
Number of sells
-
11
-
Price
-
$10.09
Institutional Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q3 2022
As of 30 Sep 2022 CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) had 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,151,664 shares of stock of the company.
Largest 10 holders included Saba Capital Management, L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, MARSHALL WACE, LLP, Periscope Capital Inc., D. E. Shaw & Co., Inc., HSBC HOLDINGS PLC, JANUS HENDERSON GROUP PLC, Polar Asset Management Partners Inc., FIR TREE CAPITAL MANAGEMENT LP, and HGC Investment Management Inc..
This table shows 65 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.